Linked Life Data

16133397

Source:http://linkedlifedata.com/resource/pubmed/id/16133397

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2005-11-14
pubmed:abstractText
The purpose of this study was to investigate the pitfalls of using 2-[18F]-fluoro-2-deoxy-D: -glucose positron emission tomography (FDG-PET) for the evaluation of osteoblastic bone metastases in patients with breast cancer by comparing it with (99m)Tc-hydroxymethylene diphosphonate bone scintigraphy.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1619-7070
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1253-8
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.
pubmed:affiliation
Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. tootuka@koto.kpu-m.ac.jp
pubmed:publicationType
Journal Article, Controlled Clinical Trial